Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
BACKGROUND: In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain. METHODS: We randomly assigned 11,140 patients with type 2 diabetes to undergo either standard glucose control or intensive glucose control, defined as the use of gliclazide...
Main Authors: | Patel, A, MacMahon, S, Chalmers, J, Neal, B, Billot, L, Woodward, M, Marre, M, Cooper, M, Glasziou, P, Grobbee, D, Hamet, P, Harrap, S, Heller, S, Liu, L, Mancia, G, Mogensen, C, Pan, C, Poulter, N, Rodgers, A, Williams, B, Bompoint, S, de Galan, B, Joshi, R, Travert, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
by: Patel, A, et al.
Published: (2007) -
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
by: Zoungas, S, et al.
Published: (2009) -
Lowering blood pressure reduces renal events in type 2 diabetes.
by: de Galan, B, et al.
Published: (2009) -
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
by: Zoungas, S, et al.
Published: (2012) -
Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial
by: Glasziou, P, et al.
Published: (2007)